孙家媛
专长
一、基本情况
门诊时间：每周二下午，云诊室周一至周五
二、科研项目
广东省医学科研基金面上项目，A2017023,ZNF780AcircRNA通过调控RFC3表达对乳腺癌进展的研究(,主持)
广东省科技社会发展攻关项目，81372818),早期乳腺癌保乳术后全乳腺大分割放射治疗(HF-WBI) 临床研究，(第二负责人)
国家自然科学基金青年项目，81803050,甲状腺素受体交互子13 (TRIP13) 诱导三阴型乳腺癌放疗抵抗的分子机制(第二负责人)
国家自然科学基金面上项目，81872459,TMSB10诱导三阴性乳腺癌放疗抵抗的分子机制，(第三参与人)
三、临床研究及新技术
人工智能辅助乳腺癌全切术后一站式放疗的II期临床研究(主持）
人工智能辅助乳腺癌保乳术后一站式放疗的II期临床研究（第二负责人）
基于结构影像引导的放疗（SGRT）技术在乳腺癌术后放疗中的应用(主持）
T1-2N1M0的乳腺癌全乳切除术后放疗加和不加内乳照射的III期随机开放临床研究(主持）
T1-2N2-3M0的乳腺癌全乳切除术后放疗加和不加内乳照射的III期随机开放临床研究基于结构影像引导的放疗（SGRT）技术在乳腺癌术后放疗中的应用（第二负责人）
四、代表性论著
1. Sun JY#,Wu SG,Chen SY,Li FY,Lin HX,Chen YX,He ZY*.Adjuvant radiation therapy and survival for adenoid cystic carcinoma of the breast.Breast,2017,31:214-218
2. Sun JY#,Wu SG,Li FY,Lin HX,He ZY*.Progesterone receptor loss identifies hormone receptor-positive and HER2-negative breast cancer subgroups at higherrisk of relapse:a retrospective cohort study.OncoTargetsTher,2016,9:1707-1713
3. Shuiqing Zhuo#,Jiayuan Sun#,Chang,Longzhong Liu,Sheng*Li.Dual-source dual-energy thin-section CT combined with small field of view technique forsmall lymph node in thyroid cancer:a retrospective diagnostic study.Gland Surg.2021 Apr;10(4):1347-1358.
4. Sun JY#,Zhou J,Zhang WW,Li FY,He ZY,Wu SG.F.Tubular carcinomas of the breast:an epidemiologic study.Future Oncol.2018 Dec;14(29):3037-3047.
5. Wu SG#,Sun JY#,Zhou J,LiFY,Lin Q,Lin HX,Guan XX,He ZY*.Number of negative lymph nodes is associated with disease-free survival in patients with breast cancer.BMC Cancer,2015,15:43.
6. Zhou J#,Sun JY#,Chen SY,LiFY,Lin HX,Wu SG,He ZY*.Prognostic value of lymph node ratio in patients with small-cell carcinoma of the cervix based on data from a large national registry.OncoTargets Ther.2015,9:67-73.
7. Wu SG#,Sun JY#,Yang LC,Zhou J,Li FY,Li Q,Lin HX,Lin Q,HeZY*.Prognosis of patients with esophageal squamous cell carcinoma after esophagectomy using the log odds of positive lymph nodes.Oncotarget.2015,6(34):36911-22.
8. Juan Zhou#,Jing Ran,Zhen-Yu He,Song Quan,Qiong-Hua Chen,San-Gang Wu, Jia-Yuan Sun*.Tailoring Pelvic Lymphadenectomy for Patients with Stage IA2,IB1,and IIA1 Uterine Cervical Cancer.Journal of Cancer.2015,6(4):377-381.
9. Yixin Cheng #Pengkun Zhang2,Yulin Huang ,Zhihui Zhang ,Jia-Yuan Sun,Zhenyu He.Development and validation of nomograms to predict survival in patients with invasive micropapillary carcinoma of the breast.BMJ Open.2023 Feb 21;13(2).
更新时间：2025.8.22
